Combined distance geometry analysis of dihydrofolate reductase inhibition by quinazolines and triazines

Journal of Medicinal Chemistry
1983.0

Abstract

Guided by the success of distance geometry in explaining the inhibition of dihydrofolate reductase by 68 quinazolines, we have made a combined analysis on the inhibition of rat liver dihydrofolate reductase by 33 triazines and 15 quinazolines. The model gave a fit having the correlation coefficient 0.892 and root mean square (rms) deviation 0.596 in log (1/C50) units. The model was applied to predict the biological activity of 91 compounds. The predicted values showed an rms deviation of 0.907 and a correlation coefficient of 0.790. The present study suggested the synthesis of some triazines as possible potent dihydrofolate inhibitors. The site geometry was compared with the crystal structure of a triazine bound to chicken liver dihydrofolate reductase, and a good correlation has been found.

Knowledge Graph

Similar Paper

Combined distance geometry analysis of dihydrofolate reductase inhibition by quinazolines and triazines
Journal of Medicinal Chemistry 1983.0
A general distance-geometry three-dimensional receptor model for diverse dihydrofolate reductase inhibitors
Journal of Medicinal Chemistry 1984.0
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: A demonstration using Escherichia coli dihydrofolate reductase inhibitors
Journal of Medicinal Chemistry 1985.0
Inhibition of dihydrofolate reductase. Structure-activity correlations of quinazolines
Journal of Medicinal Chemistry 1976.0
Inhibition of human dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazines. A quantitative structure-activity relationship analysis
Journal of Medicinal Chemistry 1984.0
Crystallography, quantitative structure-activity relationships, (QSAR) and molecular graphics in a comparative analysis of the inhibition of dihydrofolate reductase from chicken liver and Lactobacillus casei by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazines
Journal of Medicinal Chemistry 1984.0
Inhibition of dihydrofolate reductase: structure-activity correlations of 2,4-diamino-5-benzylpyrimidines based upon molecular shape analysis
Journal of Medicinal Chemistry 1981.0
Inhibition of chicken liver dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines. A QSAR and graphics analysis
Journal of Medicinal Chemistry 1986.0
Synthesis, in vitro antitumor activity, dihydrofolate reductase inhibition, DNA intercalation and structure–activity relationship studies of 1,3,5-triazine analogues
Bioorganic & Medicinal Chemistry Letters 2016.0
Comparison of quantitative structure-activity relationships of the inhibition of leukemia cells in culture with the inhibition of dihydrofolate reductase from leukemia cells and other cell types
Journal of Medicinal Chemistry 1982.0